Bradley & Co. Private Wealth Management, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 59 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bradley & Co. Private Wealth Management, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$374
-25.5%
2000.0%0.00%
Q2 2023$502
+43.4%
2000.0%0.00%
Q1 2023$350
-58.8%
2000.0%0.00%
-100.0%
Q4 2022$8502000.0%0.00%
Q3 2022$02000.0%0.00%
Q2 2022$02000.0%0.00%
Q1 2022$0
-100.0%
2000.0%0.00%
-100.0%
Q4 2021$1,0000.0%2000.0%0.00%0.0%
Q3 2021$1,0000.0%2000.0%0.00%0.0%
Q2 2021$1,0000.0%2000.0%0.00%0.0%
Q1 2021$1,0002000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders